Background: Many patients with Crohn's disease will develop complications that
| INTRODUCTION

Inflammatory bowel disease encompasses both ulcerative colitis and
Crohn's disease. These diseases are chronic inflammatory disorders that primarily affect the bowel and cause significant morbidity and mortality in affected patients. 1 Crohn's disease may involve any part of the gastrointestinal tract and is often associated with extraintestinal manifestations, perianal disease, strictures, and fistulas. Patients with stricturing and fistulising disease can develop bowel obstructions and abscesses, often requiring surgery. 2 It has been estimated that 40%-70% of patients with Crohn's disease will require surgery at some point during their disease course. 3, 4 Most patients who have surgery for their Crohn's disease will have recurrence of their disease; therefore, postoperative prevention is an important approach to treatment. Recurrence is typically classified into clinical recurrence (predominantly symptom based), endoscopic recurrence, and serologic or biologic recurrence. 5 It has been
reported that approximately 50%-60% of patients will experience recurrent disease requiring reoperation. 6 Some studies have suggested that African-Americans with
Crohn's disease may have a more severe disease course than their
Caucasian counterparts. For instance, it has been shown in AfricanAmerican children with Crohn's disease that there was an increased frequency of readmissions, decreased likelihood of remission, and decreased time intervals of steroid-free remission in comparison to Caucasian children, despite similar follow-up with their providers. 7, 8 Studies in adults have found that African-Americans with Crohn's disease were more likely to undergo surgery and often have more penetrating and stricturing disease than Caucasian patients. 9, 10 Furthermore, it has been shown that African-Americans with Crohn's disease are more likely to have postoperative complications than Caucasians. 11 However, there are no studies to date that have assessed racial differences in recurrence in postoperative Crohn's disease.
In the present study, we aimed to assess the risk of postoperative recurrence in African-Americans with Crohn's disease in comparison to Caucasian Crohn's disease patients. Outcomes of assessment included clinical index consisting of symptom assessment and objective indices including endoscopic, biologic, and histologic scores. 
| ME TH ODS
| Outcomes
The primary endpoint was clinical and endoscopic remission at 6- (SES-CD) 13 of 0 (no ulcers or inflammation in any location). We adopted SES-CD instead of Rutgeerts score for this study, so that the degree of inflammation in the ileum and colon could be quantified with a single scoring system. Two-thirds of SES-CD data were prospectively assessed by the endoscopist and the remaining of the data were retrospectively calculated based on the reports and images by two study investigators (AY and AS) when possible.
When the sites of anastomosis were not evaluated, data were excluded from the analysis. For subgroup analysis, Rutgeerts score was used to assess endoscopic recurrence among those patients who underwent ileocolectomy/ileocecectomy and had mainly ileal disease.
14 Secondary endpoints included biological and histologic remission.
Biological remission was defined as a negative C-reactive protein (CRP) (<3 mg/L, the cut-off for negative at our institution) and histologic remission as the absence of any active inflammation on biopsies. 15 
| Statistical analysis
Continuous variables were expressed as median and interquartile range (IQR). Differences in the means between subgroups were compared using Mann-Whitney U test. Comparisons between categorical variables were analysed using the Fisher's exact test. A P <0.05 was considered statistically significant.
The primary outcome of 6-12 months postoperative recurrence was analysed using univariate and multivariate comparisons among African-American and Caucasian patients. Univariate predictor variables with a P value <0.10 were included in the multivariate analysis. We used the backward elimination method for multivariate analysis.
In order to reduce the effect of treatment-selection bias and potential confounding in this observational study, we performed adjustment for significant differences in the baseline characteristics of patients with propensity score matching with nearest-neighbour matching without replacement. 16, 17 Patients with missing data were excluded from the matching. Data were matched with smoking status, age, previous surgery, and naïve for anti-TNF agents in a 1:3 ratio of African-Americans to Caucasians.
For all statistical analyses, data were analysed by EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), 18 which is a graphical user interface for R (The R Foundation for Statistical
Computing, version 2.13.0, Vienna, Austria).
| RESULTS
There As shown in Figure 1A , there was no significant difference in endoscopic remission between African-American and Caucasian patients (50% vs 42%, P = 0.76) at 6-12 months after surgery.
Among the 80% of patients who had undergone an ileocecectomy or ileocolectomy, similar results were seen when endoscopic remission was defined as Rutgeerts score ≤1 (African-American 64% analysis (OR 0.33, 95% CI 0.11-1.01, P = 0.07) and was significantly associated with a lower risk of endoscopic recurrence on multivariate analysis (OR 0.37, 95% 0.14-0.99, P = 0.047).
As shown in Table 3 , African-American race was significantly associated with clinical recurrence on both univariate (OR 6.76, 95% CI No factors were found to have a significant effect on biologic recurrence, including African-American race (Table S1 ). For histologic recurrence, previous surgery was found to be significant on univariate, but not multivariate analysis (Table S2) .
After propensity score matching with adjustments for smoking, age, perianal disease, and anti-TNF naïve status, the characteristics of the two groups were similar in regard to all clinical parameters (Table S3 ). As shown in Figure 1B , after propensity score matching, there was no significant difference in rates of endoscopic remission between the two groups, but rates of clinical remission were significantly lower amongst African-Americans in comparison to Caucasians (32% vs 68%, P = 0.005). No differences were observed between the two groups for biologic and histologic remission.
| Characterisation of Harvey-Bradshaw index
A breakdown of the postoperative Harvey-Bradshaw index between African-American and Caucasian patients was done to more closely evaluate effects on clinical recurrence (Table 4) F I G U R E 1 A, Crude data on remission rates in AA and CAU patients. There is a significant difference in rates of clinical remission between AA and CAU (P = 0.008). There were no significant differences in endoscopic, biologic, or histologic remission between the two groups. B, Data on remission rates in AA and CAU patients following propensity score matching. There remains a significant difference in the rate of clinical remission in AA in comparison to CAU (P = 0.005). Again, there was no difference between the two groups in endoscopic, biologic, or histologic remission (P = 0.16) and abdominal pain (P = 0.16) also trended to be higher in African-American patients, but there were no differences in the subscores of number of liquid stools and abdominal mass.
| DISCUSSION
The literature on racial differences in postoperative recurrence is extremely limited. In the present study, we assessed differences in postoperative recurrence (endoscopic, clinical, biologic, and histologic)
between African-American and Caucasian patients with Crohn's disease at a single academic centre. We found no significant difference between African-American and Caucasian patients in objective measures of recurrence (endoscopic, biologic, and histologic) at 6-12 months after surgery. However, African-American patients had a significant risk of postoperative clinical recurrence, which was primarily attributed to subjective differences in general well-being.
Prior studies have postulated that Crohn's disease may have a more severe course in African-American patients. Our group demonstrated that African-American patients with Crohn's disease were more likely to undergo Crohn's disease-related surgery in comparison to their Caucasian counterparts, suggesting a more severe disease course in these patients. 10 Dotson et al used symptom scoring and physician assessments to determine differences in rates of remission in African-American children in comparison to Caucasian children with Crohn's disease. They found that the African-American children were less likely to be in remission based on the physician global assessment, and less likely to have corticosteroid-free remission based on both the physician global assessment and the Crohn's Disease Activity Index (CDAI). 7 Similarly, our study showed that African-American patients had more clinical symptoms postoperatively than Caucasian patients; however, no differences in objective measurements of disease were identified. Our study suggests that disease phenotype may not be more severe in African-Americans in comparison to Caucasians when looking at objective measures of disease activity.
Furthermore, our study raises caution when assessing disease activity or postoperative recurrence with symptom scores alone.
Regueiro et al found that there was poor correlation between endoscopic scores and clinical disease scores (using CDAI) in postoperative Crohn's disease at 1 year; 19 however, our study is the first to find a racial difference in the discrepancy between clinical symptoms and objective findings. This is important when conducting studies including multiethnic populations and further illustrates the need for objective endpoints.
Our study also found that African-American patients trended to however, additional studies are required to clarify these points.
There are several well-known risk factors for postoperative recurrence in Crohn's disease including smoking, penetrating disease, and history of surgery. [22] [23] [24] [25] Our study did not reproduce the same results in relation to the effect of known risk factors on recurrence, which may be due in part to the small power of the study. Nevertheless, previous studies did not address race when looking at risk factors for postoperative recurrence. Therefore, the findings in our study may be due in part to the small power of the study, but race may also have an impact on other risk factors for recurrence.
There are a few limitations to our study. Firstly, the study was done retrospectively at a single academic centre using a prospec- however, there was no overall difference in anti-TNF use between the two groups and all patients who initiated anti-TNF therapy postoperatively, started them within 2-4 weeks of surgery. Finally, the relatively small sample size may have diminished some of the power in our study. However, our sample size is comparable to other single-centre studies looking at racial differences in inflammatory bowel disease. 21 Furthermore, we applied both univariate and multivariate logistic regression, in addition to propensity score matching to control for confounders.
To our knowledge, this is the first study looking at racial disparities in postoperative recurrence in Crohn's disease. We found no significant difference between African-American and Caucasian
Crohn's disease patients in objective measures of recurrence after surgery; however, African-American patients were significantly more likely to have postoperative clinical recurrence. It is unclear whether the differences in clinical recurrence reflect occult racial/ ethnic disparity, genetic differences between races that create different clinical symptoms despite similar objective outcomes, physician bias in the subjective scoring of patient well-being, or unconscious lack of effective communication and support by physicians.
Endoscopy is the mainstay of postoperative evaluation; however, this study raises important questions as clinical symptoms are often used as a guide to initiate or switch therapies. Further studies are warranted to address the causes for these disparities, but the results of our study raise caution on using clinical indices alone when assessing postoperative outcomes in African-American Crohn's disease patients.
